Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor 8 Deficiency, Congenital”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05568719
What this trial is testing

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Who this might be right for
Hemophilia AHemophilia B
Pfizer 173
Not applicableLooking for participantsNCT06816056
What this trial is testing

Manual Therapy in Hemophilic Arthropathy of the Ankle

Who this might be right for
Hemophilia A
Investigación en Hemofilia y Fisioterapia 13
Not applicableUnknownNCT04775888
What this trial is testing

Accessibility of Prophylaxis and On-demand Treatment for Persons With Haemophilia and Other Coagulation Deficiencies

Who this might be right for
Health Services AccessibilityBlood Coagulation Factor Deficiencies
RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône 500
Large-scale testing (Phase 3)Study completedNCT01913405
What this trial is testing

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

Who this might be right for
Hemophilia A
Baxalta now part of Shire 30
Testing effectiveness (Phase 2)Study completedNCT03370172
What this trial is testing

BAX 888 in Male Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Not applicableNot Yet RecruitingNCT07452575
What this trial is testing

3D Ultrasound in Hemophilic Ankles

Who this might be right for
Hemophilia
The Hospital for Sick Children 11
Post-approval studies (Phase 4)Study completedNCT00950170
What this trial is testing

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

Who this might be right for
Hemophilia A
Pfizer 23
Not applicableStudy completedNCT03430154
What this trial is testing

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

Who this might be right for
Haemophilia A, Haemophilia B, Obesity
Novo Nordisk A/S 317
Large-scale testing (Phase 3)Study completedNCT01568580
What this trial is testing

Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A

Who this might be right for
Hemophilia A
Green Cross Corporation 71
Not applicableStudy completedNCT03507582
What this trial is testing

Virtual Reality for Hemophilia

Who this might be right for
Hemophilia AHemophilia B
Nationwide Children's Hospital 25
Not applicableStudy completedNCT04133883
What this trial is testing

Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint Examination

Who this might be right for
Hemophilia A
Swedish Orphan Biovitrum 88
Not applicableStudy completedNCT03834727
What this trial is testing

Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders

Who this might be right for
Hemophilia ABleeding Disorder
Oregon Health and Science University 256
Post-approval studies (Phase 4)Active Not RecruitingNCT05181618
What this trial is testing

Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Who this might be right for
Severe Hemophilia AModerate Hemophilia A
Hoffmann-La Roche 136
Not applicableStudy completedNCT00697385
What this trial is testing

The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders

Who this might be right for
vonWillebrand DiseaseHemophiliaPlatelet Coagulation Disorders
Mary M. Gooley Hemophilia Center 13
Large-scale testing (Phase 3)Study completedNCT01233258
What this trial is testing

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 80
Large-scale testing (Phase 3)Study completedNCT01125813
What this trial is testing

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Octapharma 32
Large-scale testing (Phase 3)Study completedNCT00000582
What this trial is testing

Cooperative Study of Factor VIII Inhibitors

Who this might be right for
Blood Coagulation DisordersHematologic DiseasesHemophilia A+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT05628558
What this trial is testing

Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A

Who this might be right for
Hemophilia A, MildDesmopressinFactor VIII
Groupe Maladies hémorragiques de Bretagne 800
Large-scale testing (Phase 3)Ended earlyNCT05695391
What this trial is testing

Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery

Who this might be right for
Hemophilia
Laboratoire français de Fractionnement et de Biotechnologies 2
Large-scale testing (Phase 3)Study completedNCT00141843
What this trial is testing

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation